It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Rectal and Anal Carcinomas Validation Study

Clinical Trial Title: 
Prospective validation study for rectal and anal carcinomas.
Clinical Trial Protocol ID: 
14082603
Clinical Trial Investigator Name: 
Joshua Melson, MD, MPH
Clinical Trial Protocol Description: 

Evaluate a test that may accurately predict an individual patient’s predicted response to chemo/radiation therapy. Interested subjects will sign a medical release form allowing Rush to obtain information about your initial diagnosis, treatment of your tumor and information about the course of your healthcare. A sample of your tumor will be sent to the sponsor.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have stage II or III rectal adenocarcinoma OR stage II or III anal squamous cell carcinoma.
  • Be greater than 18 years old.
  • Be a patient who will undergo chemo and/or radiation therapy and have surgical resection.

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Gastrointestinal Cancers
Contact Email: 
Contact Phone: 
(312) 942-3466
Contact Name: 
Krista Shawron